Research

Hormonal

Naltrexone/bupropion, lorcaserin, and orlistat are significantly less effective than phentermine for achieving ≥5% weight loss over 6 months.

Naltrexone/bupropion, lorcaserin, and orlistat are less likely to produce significant weight loss (≥5%) compared to phentermine over 6 months when combined with lifestyle changes.

ModerateRefutesMEDIUM confidence
At the 6 month time point, the ORs for each AOM group, compared with the phentermine group, were as follows: ... naltrexone/bupropion, 0.089 (95% CI, 0.022–0.355); lorcaserin, 0.221 (95% CI, 0.074–0.661); and orlistat, 0.281 (95% CI, 0.092–0.863).
Ji-Eun Song et al. · Drug Design Development and Therapy · 2024

Why this rating

Same study limitations.

Source

Comparison of the Efficacy of Anti-Obesity Medications in Real-World Practice

Ji-Eun Song et al. · Drug Design Development and Therapy · 2024

DOI 10.2147/dddt.s445415

cohort · n=205Cited 16×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →